Document is current
Any future updates will be listed below
-
Authors
Lu, Ashley
Chen, Wei-Ting
Dalby, Maria
Sainz Garcia, Diego
Vanheusden, Marisa
de Vries, Luuk E.
van Lieshout, Veerle
Martirosyan, Araks
Craessaerts, Katleen
Moonen, Sebastiaan
Zielonka, Magdalena https://orcid.org/0000-0001-9641-9778
Chrysidou, Iordana
Misbaer, Anke
Wolfs, Leen
Pavie, Benjamin https://orcid.org/0000-0002-0249-3844
Swaab, Dick
Thal, Dietmar Rudolf https://orcid.org/0000-0002-1036-1075
Huitinga, Inge https://orcid.org/0000-0002-4878-8920
Rozemuller, Annemieke https://orcid.org/0000-0003-2528-4428
Rohde, Susan Karijn
Hulsman, Marc https://orcid.org/0000-0002-9889-3606
Holstege, Henne https://orcid.org/0000-0002-7688-3087
Balice-Gordon, Rita
Plath, Niels https://orcid.org/0000-0003-3300-2814
Fiers, Mark https://orcid.org/0000-0001-5694-2409
De Strooper, Bart https://orcid.org/0000-0001-5455-5819
- License Information
-
More Information
Article History
Received: 11 July 2025
Accepted: 1 April 2026
First Online: 4 June 2026
Competing interests
: W.-T.C, A.L., M.D., D.S.G., M.V., A. Martirosyan, A. Misbaer, L.W., R.B.-G. and N.P. are, or have been, employed by Muna Therapeutics. B.D.S. is a consultant for Muna Therapeutics and is, or has been, a consultant for Eli Lilly, Biogen, Janssen Pharmaceuticals, Eisai, AbbVie and other biotechnology companies. B.D.S is a scientific founder of Augustine Therapeutics and a scientific founder and a minor stockholder of Muna Therapeutics. H.H. and M.F. are, or have been, consultants for Muna Therapeutics. D.R.T. collaborated with Novartis Pharma AG (Switzerland), Probiodrug (Germany), ADx NeuroSciences (Belgium) and GE HealthCare (UK) and received consultant honoraria from Muna Therapeutics (Denmark). The remaining authors declare no competing interests.
